Protalix Biotherapeutics Inc (PLX) — Financial Flexibility Index
Protalix Biotherapeutics Inc (PLX) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of $3.27 Million (operating CF $2.03 Million minus capex $1.24 Million) represents 0% of total liabilities ($34.12 Million). Check Protalix Biotherapeutics Inc (PLX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Protalix Biotherapeutics Inc Financial Flexibility Index (1996–2025)
Historical Financial Flexibility Index trend for Protalix Biotherapeutics Inc across 30 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Protalix Biotherapeutics Inc.
Annual Financial Flexibility Index for Protalix Biotherapeutics Inc (1996–2025)
Year-by-year free cash flow to debt coverage for Protalix Biotherapeutics Inc. Explore PLX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.30x | $-10.36 Million | $-11.99 Million | $34.12 Million | ▼ -192.1% |
| 2024 | 0.33x | $9.96 Million | $8.67 Million | $30.21 Million | ▲ +10020.3% |
| 2023 | 0.00x | $-169.00K | $-1.32 Million | $50.87 Million | ▲ +99.1% |
| 2022 | -0.37x | $-24.37 Million | $-25.00 Million | $66.43 Million | ▼ -231.3% |
| 2021 | -0.11x | $-8.83 Million | $-10.29 Million | $79.70 Million | ▲ +58.7% |
| 2020 | -0.27x | $-25.45 Million | $-26.11 Million | $94.97 Million | ▼ -65.6% |
| 2019 | -0.16x | $-18.73 Million | $-19.36 Million | $115.71 Million | ▼ -161.6% |
| 2018 | -0.06x | $-7.06 Million | $-7.74 Million | $114.01 Million | ▲ +29.0% |
| 2017 | -0.09x | $-9.02 Million | $-9.99 Million | $103.51 Million | ▲ +74.3% |
| 2016 | -0.34x | $-31.25 Million | $-32.10 Million | $92.20 Million | ▼ -22.9% |
| 2015 | -0.28x | $-23.82 Million | $-24.28 Million | $86.38 Million | ▼ -29.7% |
| 2014 | -0.21x | $-28.50 Million | $-29.28 Million | $134.07 Million | ▼ -3.7% |
| 2013 | -0.21x | $-28.76 Million | $-30.65 Million | $140.28 Million | ▼ -722.7% |
| 2012 | 0.03x | $2.70 Million | $635.00K | $82.08 Million | ▲ +114.4% |
| 2011 | -0.23x | $-17.86 Million | $-23.57 Million | $77.88 Million | ▲ +43.0% |
| 2010 | -0.40x | $-30.61 Million | $-38.46 Million | $76.05 Million | ▼ -165.8% |
| 2009 | 0.61x | $50.65 Million | $44.45 Million | $82.79 Million | ▲ +131.3% |
| 2008 | -1.96x | $-12.64 Million | $-16.02 Million | $6.46 Million | ▼ -7.3% |
| 2007 | -1.82x | $-8.11 Million | $-10.45 Million | $4.45 Million | ▼ -16.0% |
| 2006 | -1.57x | $-4.25 Million | $-5.09 Million | $2.70 Million | ▼ -58.1% |
| 2005 | -0.99x | $-72.47K | $-72.47K | $72.93K | ▲ +58.3% |
| 2004 | -2.39x | $-168.12K | $-168.12K | $70.47K | ▼ -37.6% |
| 2003 | -1.73x | $-136.68K | $-136.68K | $78.82K | ▲ +6.5% |
| 2002 | -1.85x | $-146.59K | $-146.59K | $79.07K | ▲ +81.9% |
| 2001 | -10.22x | $-789.43K | $-789.43K | $77.28K | ▼ -10683.7% |
| 2000 | -0.09x | $-53.11K | $-53.11K | $560.61K | ▲ +96.8% |
| 1999 | -3.00x | $-1.38 Million | $-1.41 Million | $459.36K | ▼ -453.1% |
| 1998 | -0.54x | $-769.54K | $-909.52K | $1.42 Million | ▼ -1534.4% |
| 1997 | -0.03x | $-247.92K | $-247.92K | $7.47 Million | ▼ -500.7% |
| 1996 | -0.01x | $-40.57K | $-40.57K | $7.34 Million | — |